B U S I N E S S | Friday, December 18, 1998 |
|
weather n
spotlight today's calendar |
India may recognise product patents NEW DELHI, Dec 17 - The introduction of the Patents (Amendment) Bill, 1998, granting exclusive marketing rights for a period of five years to manufacturers of pharmaceuticals and agricultural chemicals marks Indias recognition of product patents. Patents Bill in nutshell
|
US company floats $ 100 million fund NEW DELHI, Dec 17 New York International Inc, the global arm of New York Life Insurance Company,today announced the launching of a $ 100 million fund to invest in the Indian economy. Haryana exports rise 64.4 per cent |
The
Dutch like it LSE
members to widen reach Insure
films, says FICCI |
||||||||
India may recognise product
patents NEW DELHI, Dec 17 - The introduction of the Patents (Amendment) Bill, 1998, granting exclusive marketing rights (EMRs) for a period of five years to manufacturers of pharmaceuticals and agricultural chemicals marks Indias recognition of product patents. Till now the country has been recognising only process patents, which meant an Indian manufacturer could manufacture any pharmaceutical drugs or agricultural chemicals available in the international market with a different process. The decision to introduce the Bill to grant EMRs followed Indias ratifying the World Trade Organisation agreement, which also contained a provision on trade related aspects of intellectual property rights (TRIPs). The agreement came into force on January 1, 1995. The TRIPs agreement prescribes the minimum standards to be adopted by the member countries in respect of eight areas of intellectual property. Though India has a transition period of five years with effect from January 1, 1995, to apply the provisions of the agreement and an additional period of five years for extending product patent protection to areas of technology not protected so far, certain obligations were required to be fulfilled with effect from the date the agreement came into being. Notwithstanding the transition period, the agreement on TRIPs had a clause which said that member countries which do not provide for product patents in the areas of pharmaceuticals and agricultural chemicals provide for a means to receive product patent applications for pharmaceuticals and agricultural chemicals. Pending the clearance of the product patent application, the member countries were required to grant exclusive marketing rights for a period of five years or until the patent was granted or rejected, whichever was shorter. Since the Patents Act, 1970, in India did not provide for the grant of product patents in the fields of agricultural chemicals and pharmaceuticals, it is required to grant exclusive marketing rights to the applicants of product patents. Under the proposed amendment, where an applicant had filed for patent rights before any invention was made in India or abroad before January 1, 1995, and has received the approval to sell or distribute the article or substance from the designated authority of the Central Government, he would now have exclusive right by himself, his agents or licensees to sell or distribute in India the article or substance for which patent has been sought. The Government, while granting EMRs has, however, made a provision in the Bill which says that whenever the Government feels it necessary or expedient in public interest, it can allow the sale or distribution of the article by a person other than a person to whom exclusive marketing rights have been granted. Apart from preserving the Governments ability to intervene, further restrictions on inventions made in India are also proposed to be removed. The Bill contains a provision for omitting Section 39 of the Patents Act, 1970, which deals with these restrictions. Certain safeguards are proposed to be provided in the form of public non-commercial use, price fixation and compulsory licensing. The Bill also contains some measures in the interest of national security. India had initially fulfilled the obligations under the WTO by issuing an Ordinance on amending the Patents Act in December 1994. Subsequently, the Bill was passed by the Lok Sabha in 1995 and then introduced in the Rajya Sabha where it was referred to a Select Committee of the House. As the Select Committee did not submit its report before the dissolution of the tenth Lok Sabha, the Bill lapsed. Recently, the USA raised a dispute against India at the WTO alleging non-fulfilment of Indias obligations with regard to the TRIPs agreement. A panel set up by the Dispute Settlement Body of the WTO examined the allegations made by the USA and ruled that India had not complied with the obligations. On an appeal made by India, the matter was considered by the appellate body of the WTO which also recommended that India take the necessary steps to comply with its obligations. It was subsequently
decided that this be done by April 19, 1999. Failure to
comply with these obligations within the stipulated
period would entail action against India in terms of the
Dispute Settlement understanding of the WTO Agreement. Patents Bill in nutshell * The Patents Act, 1970, does not provide for product patents in pharmaceuticals and agricultural chemicals. * The Patents (Amendment) Bill, 1998, grants exclusive marketing rights to manufacturers of pharmaceuticals and agricultural chemicals. * The amendment to the
Patents Act is required under the WTO agreement. |
Attacks on Iraq trigger panic
selling MUMBAI, Dec 17 (PTI) The sensex dropped by over 72 points as equities nosedived on Bombay Stock Exchange (BSE) here today on panic selling induced by reports of air attacks on Iraq jointly by the USA and Britain. Dealers said that reports of a series of military strikes against Iraq for its failure to cooperate with the United Nations Weapons Inspectors created chaos in the market which led to panic selling by leading operators in all bourses of the country. Foreign institutional investors (FIIs) were, however, buyers of select pharmaceutical and software shares such as Dr Reddy, Glaxo, Satyam Computers, Zee Tele and ITC which were attractive at lower levels. Some deals were effected for covering up positions ahead of the current settlement. Local institutions supported MTNL, Mah & Mah, Glaxo and Reliance in small lots for squaring up positions. Barring a few scrips, all-round selling pressure engulfed the market bringing down the sensex below 2900-mark level. Activity was also affected by the procedural wrangles which were likely to arise over the introduction of the Patents (Amendment) Bill in the Rajya Sabha. The Left parties had opposed the Bill in the House before introduction. The BSE sensitive index opened lower at 2884.65 and fluctuated between 2919.47 and 2855.10. The sensex closed at 2864.44, with a fall of 72.48 points from the previous close of 2936.92. The broad-based BSE-100 closed with a decline of 32.50 points at 1267.86 from the overnight close of 1300.36. The BSE-200 ended lower at 294.05 and the Dollex at 115.05 from the last close of 301.07 and 117.80 respectively. Among the pharmaceuticals Glaxo steadied to close at 605.75 from the last close of 609.00. Dr reddys Lab reduced the losses to close at 445.75 from 448.75 previously. Knoll Pharma gained by 12.25 to 485.75 and Pfizer by 20.00 to 839.50. The total turnover on the
BOLT system was Rs 1354.07 crore. Satyam Computers was
the most prominent scrip with a turnover of Rs 311.36
crore. Zee Tele totalled Rs 182.16 crore, ITC Rs 168.44
crore, Pentafour Software Rs 110.80 crore and Telco Rs
88.89 crore. |
US company floats $ 100
million fund NEW DELHI, Dec 17 New York International Inc, the global arm of New York Life Insurance Company,today announced the launching of a $ 100 million fund to invest in the Indian economy. The fund will focus on investments in sectors such as telecommunications, infrastructure projects, power supply to industrial users, software and export related industries. Vickers Ballas Securities India Pvt. Ltd will serve as the investment advisor to New York Life International Fund. Announcing the launch, the President of New York Life International, Mr Michael Nocera said that this is the single largest equity commitment of the company in Asia. The funds investment will, however, not be limited to the infrastructure sector and the fund will also look at other high growth areas. Mr Nocera said the fund would like to invest with strong Indian entrepreneurs who have a proven track record for periods usually up to seven years. Regarding the Indian insurance sector, Mr Nocera said that the company would like to participate in it once the legislation is put in place. The company has already held discussions with several Indian companies for setting up possible joint ventures. No commitments have been made so far. On the issue of foreign
equity cap as envisaged in the Insurance Regulatory
Authority (IRA) Bill, Mr Nocera said that ideally
we would like to set up a joint venture in which we hold
a 50 per cent stake. But at the same time we are
not unhappy with the 26 per cent cap. |
Haryana exports rise 64.4 per cent CHANDIGARH, Dec 17 Mr P.K. Gupta, General Manager, Punjab National Bank PNB, said here today the exports from Haryana during the first half of the current financial year has increased by 64.4 per cent from Rs 1018.67 crore (Sept 97) to Rs 1674.64 crore (Sept 98). Banks handled export business of Rs 809.41 crore as against Rs 647.14 crore during the corresponding period last year, thus registering an increase of Rs 162.27 crore. He was speaking at the
state level Export Promotion Committee, Haryana convened
by the PNB. The chief guest of the meeting was Ms Sudha
Sharma, Commissioner and Secretary, Institutional Finance
and Credit Control, Haryana. Mr R.P. Gupta, General
Manager of PNB, Mr S.S. Dhillon, Director of
Institutional Finance and Credit Control, Haryana, Mr U.S
Paliwal, Deputy General Manager, of the RBI, and
controlling heads of member banks in the state were among
those who attended. |
Euro? Whats it? IT may be the greatest attempt in centuries to unite Europe but most British people seem blissfully ignorant about the euro. With less than three weeks before its launch, a poll has found that 51 per cent of people do not have a clue that the new currency is called the euro. Guesses at its name included equarder, ecru, etu, eu and even the curo. As for the value of the euro, a mere 10 per cent of people polled by BBC-TVs Money Programme correctly said that it will be worth about 70 pence (pound 0.70). Estimates of its value against the pound ranged from one penny (pound 0.01) to eight pounds. A mere 5 per cent knew
that euro notes and coins will be introduced in the year
2002, three years after 11 EU countries lock their
currencies into Economic and Monetary Union next month.
Most people thought they could use notes and coins in the
mysterious currency from next year. The BBC interviewed
1,000 at the end of last month for the survey. |
The Dutch like it FOUR hundred years ago Amsterdam was the proud capital of the wealthiest country on earth, a city awash with silks and spices brought home by merchants who had travelled the world. So great was the Netherlands might that Samuel Pepys confided, rather indelicately, to his diary: ``Methinks, by God, the devil must shit Dutchmen. That was a long time ago. Since then the Dutch have been trampled over many times by belligerent neighbours. In peace, they have tailored their ambitions to their more modest weight in the world, combining their mercantile tradition and the asset of their geographical position to become the middlemen for a continent. Its a very
straightforward question, and just about every Dutch
person realises it said Ton Havermans, aged 39, an
Amsterdam grain dealer. Were a small country
surrounded by bigger countries, so weve always been
pro-Europe. But above all, we are a trading nation and a
nation of pragmatists. It will be a hassle, but it will
save us one hell of a lot of money. And if the
Dutch needed reminding of what is at stake, a government
brochure spells it out: more than half of what the
Netherlands produces each year is destined for export
two-thirds of it to members of the European Union
and two-thirds of its imports come from the EU. |
LSE members to widen reach LUDHIANA, Dec 17 Ludhiana Stock Exchange plans to broadbase the business of its members by facilitating trading on wide area network (WAN) using VSAT as the medium. The Board of Directors of LSE has already approved in principle the scheme and negotiations with vendors for the purchase of VSATs was at an advance stage. Mr Vishwanath Dhiri, President of LSE, told TNS here today that the WAN expansion would facilitate in creating a new customer base for the members. VSAT connectivity would enhance the reach of the LSE members to areas which were today not accessible directly and would allow investors to avail themselves of the sophisticated trading facilities provided by LSE without having to actually visit the stock exchange. Investors would benefit from this transparent and efficient system. We also plan to provide value-added services to investors in our region, including the facility of forward trading and trading in demat shares at better terms as compared to our bigger counterparts. We have received permission from SEBI for the expansion of our trading activities anywhere in India, Mr Dhiri said. Ludhiana Stock Exchange has already set up a settlement guarantee fund whereby all trades are guaranteed for payment. LSE is the second stock exchange after BSE which has introduced the modified carry forward system. This allows investors the facility of carrying forward their trades up to 90 days after payment of the necessary margins. LSE became the fourth
stock exchange after NSE, BSE and CSE to commence trading
in the unified segment where both deliveries in physical
as well as demat form were compulsorily accepted by the
buyer. Trading in demat form will facilitate a free
movement of securities from the one exchange to another
and will benefit the investors by the elimination of bad
deliveries, immediate transfer of securities, elimination
of the levy of stamp duty, reduced volume of paper,
reduced transaction costs and elimination of risks
associated with physical shares. |
Insure films, says FICCI NEW DELHI, Dec 17 (PTI) The FICCI today suggested the provision of total insurance cover, including those related to risk abandonment, personnel and liability, for the film industry. To explore the possibilities of providing novel insurance schemes to films, which was recently according the industry status, the Chamber was organising a conference tomorrow on Film Finance and Insurance in Mumbai, an FICCI press note said here today. In a paper prepared by the Chamber, it said the insurance could be provided against loss damage or destruction of equipment. Abandonment insurance loss damage or destruction of equipment. Abandonment insurance could also be opted for indemnifying promotional expenditure undertaken by film units. For the third-party
liability where a film unit might be dragged to court for
inadvertently causing injuring or damaging property, a
public liability cover could help provide compensation to
the affected party, it said. |
H |
| Nation
| Punjab | Haryana | Himachal Pradesh | Jammu & Kashmir | | Chandigarh | Editorial | Sport | | Mailbag | Spotlight | World | 50 years of Independence | Weather | | Search | Subscribe | Archive | Suggestion | Home | E-mail | |